-
Oppenheimer: We Still Love OvaScience
Wednesday, April 8, 2015 - 8:51am | 232Read More...In a report published Wednesday, Oppenheimer analyst Rohit Vanjani discussed a recent investor meeting with OvaScience Inc (NASDAQ: OVAS)'s management team, including the company's Chief Executive Officer Dr. Michelle Dipp. OvaScience noted that both patient and physician inquiries have moved...
-
Top Percentage Gainers and Losers as of 2pm 5/10/11 (FONR, CKXE, TRAK, CPE, SREV, FFHL, MED, FOSL, BMTI, HEAT, PANL, MOBI, MNKD, VRML, USAT, ETM)
Tuesday, May 10, 2011 - 2:07pm | 691Read More...Best 1) Fonar (NASDAQ: FONR): Trading up 27.3% from yesterday's close to $2.77. Fonar reported a 15% increase in revenue to $8.7 million for the third quarter. Net income came in at $0.20 per share versus $7.5 million for the same period last year. Shares set a new 52-week high of $3.20 earlier in...
-
Top Percentage Gainers and Losers as of 12pm 5/10/11 (FONR, TRAK, CKXE, CPE, FFHL MED, PTRY, GENE,BMTI, HEAT, PANL, USAT, HOLI, ITMN, VRML)
Tuesday, May 10, 2011 - 12:06pm | 549Read More...Best 1) Fonar (NASDAQ: FONR): Trading up 25.1% from yesterday's close to $2.72. Fonar reported a 15% increase in revenue to $8.7 million for the third quarter. Net income came in at $0.20 per share versus $7.5 million for the same period last year. Shares set a new 52-week high of $3.20 earlier in...
